149 related articles for article (PubMed ID: 35976169)
1. miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy.
Akpınar K; Aslan D; Fenkçi SM; Caner V
Diagnosis (Berl); 2022 Nov; 9(4):499-507. PubMed ID: 35976169
[TBL] [Abstract][Full Text] [Related]
2. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
[TBL] [Abstract][Full Text] [Related]
3. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan.
Chien HY; Chen CY; Chiu YH; Lin YC; Li WC
Int J Med Sci; 2016; 13(6):457-65. PubMed ID: 27279796
[TBL] [Abstract][Full Text] [Related]
4. Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy.
Wang J; Wang G; Liang Y; Zhou X
J Diabetes Res; 2019; 2019():5204394. PubMed ID: 31218232
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs from urinary extracellular vesicles are non-invasive early biomarkers of diabetic nephropathy in type 2 diabetes patients with the 'Asian Indian phenotype'.
Prabu P; Rome S; Sathishkumar C; Gastebois C; Meugnier E; Mohan V; Balasubramanyam M
Diabetes Metab; 2019 Jun; 45(3):276-285. PubMed ID: 30165157
[TBL] [Abstract][Full Text] [Related]
6. Potential Value of Urinary Exosome-Derived let-7c-5p in the Diagnosis and Progression of Type II Diabetic Nephropathy.
Li W; Yang S; Qiao R; Zhang J
Clin Lab; 2018 May; 64(5):709-718. PubMed ID: 29739042
[TBL] [Abstract][Full Text] [Related]
7. Circulating hsa-miR-221 as a possible diagnostic and prognostic biomarker of diabetic nephropathy.
Abdel-Tawab MS; Mohamed MG; Doudar NA; Rateb EE; Reyad HR; Elazeem NAA
Mol Biol Rep; 2023 Dec; 50(12):9793-9803. PubMed ID: 37831346
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of hsa-miR-100-5p May Be a Protective Factor in the Early Stages of Nephropathy in Type 1 Diabetes Mellitus.
Pinheiro AHG; Pereira BO; Silva LSD; Melo FTC; Souza ACCB; Leal VSG; Figueiredo PBB; Neto JFA; Santos MCD; Queiroz NNM; Felício KM; Ribeiro-Dos-Santos Â; Felício JS; Cavalcante GC
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891851
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
Dai Y; Guo M; Jiang L; Gao J
Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
[TBL] [Abstract][Full Text] [Related]
10. The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy.
Kim H; Bae YU; Jeon JS; Noh H; Park HK; Byun DW; Han DC; Ryu S; Kwon SH
J Transl Med; 2019 Jul; 17(1):236. PubMed ID: 31331349
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of urine exosomes derived from rats with diabetic kidney disease.
Mishra DD; Sahoo B; Maurya PK; Sharma R; Varughese S; Prasad N; Tiwari S
Front Endocrinol (Lausanne); 2023; 14():1157194. PubMed ID: 37251672
[TBL] [Abstract][Full Text] [Related]
12. Circulating miRNAs in Type 2 Diabetic Patients with and without Albuminuria in Malaysia.
Zahari Sham SY; Ng CT; Azwar S; Yip WK; Abdullah M; Thevandran K; Osman M; Seow HF
Kidney Blood Press Res; 2022; 47(2):81-93. PubMed ID: 35158353
[TBL] [Abstract][Full Text] [Related]
13. microRNA-29b-3p attenuates diabetic nephropathy in mice by modifying EZH2.
Zhao Y; Li D; Zhou P; Zhao Y; Kuang J
Hormones (Athens); 2023 Jun; 22(2):223-233. PubMed ID: 36692688
[TBL] [Abstract][Full Text] [Related]
14. New risk factors in diabetic nephropathy: microRNA-196-3p and microRNA-203.
Eroglu İ; Korkmaz H; Ozturk KH; Sirin FB; Sevik S; Afsar B
Minerva Endocrinol (Torino); 2022 Sep; 47(3):314-324. PubMed ID: 33331738
[TBL] [Abstract][Full Text] [Related]
15. Metformin mediates MicroRNA-21 regulated circulating matrix metalloproteinase-9 in diabetic nephropathy: an in-silico and clinical study.
Khokhar M; Roy D; Bajpai NK; Bohra GK; Yadav D; Sharma P; Purohit P
Arch Physiol Biochem; 2023 Dec; 129(6):1200-1210. PubMed ID: 34087084
[TBL] [Abstract][Full Text] [Related]
16. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.
Liu Q; Wang M; Xu T; Liang W; Yang F
J Clin Lab Anal; 2022 Feb; 36(2):e24210. PubMed ID: 34964177
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of hsa-miR-152-3p are associated with diabetic nephropathy in patients with type 2 diabetes.
Roux M; Perret C; Feigerlova E; Mohand Oumoussa B; Saulnier PJ; Proust C; Trégouët DA; Hadjadj S
Nephrol Dial Transplant; 2018 Dec; 33(12):2201-2207. PubMed ID: 29361146
[TBL] [Abstract][Full Text] [Related]
19. Decreased Urine miR-199-3p may be a Potential Biomarker for Diabetic Nephropathy via Targeting Zinc Finger E-box-Binding Protein 1.
Meng L; Li G; Liu X; Jiang J; Zhu M; Sun Y
Clin Lab; 2018 Jul; 64(7):1177-1182. PubMed ID: 30146830
[TBL] [Abstract][Full Text] [Related]
20. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.
Han Q; Zhang Y; Jiao T; Li Q; Ding X; Zhang D; Cai G; Zhu H
Nutr Diabetes; 2021 Jun; 11(1):24. PubMed ID: 34193814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
